Our friends at CB Insights put together a chart showing Amazon’s largest acquisitions in dollar value, this weekend’s infographic. . . . → Read More: Infographic – Amazon’s Largest Acquisitions
|
|||||
|
A biotechnology enterprise developing gene therapies for rare inherited diseases and neurological disorders is being acquired by pharmaceutical company Novartis AG for $8.7 billion. . . . → Read More: Gene Therapy Biotech Acquired in $8.7 Billion Deal  Comments are closed  Finance  biomedical, biotechnology, clinical trials, equity, Europe, FDA, genomics, investment, life sciences, merger, pharmaceuticals The global pharmaceutical company Roche is purchasing the cancer data management and analytics enterprise Flatiron Health in New York for $1.9 billion. . . . → Read More: Cancer Analytics Company Acquired in $1.9B Deal Comments are closed Finance biomedical, cancer, engineering, equity, FDA, genomics, investment, life sciences, medical device, merger, software Global drug maker Sanofi is acquiring a Belgian biotechnology company developing synthetic nanoscale therapeutic antibodies in a deal valued at $4.8 billion. . . . → Read More: Sanofi Buys Nano-Antibody Biotech in $4.8B Deal Comments are closed Finance biomedical, biotechnology, equity, Europe, investment, life sciences, merger, nanotechnology, pharmaceuticals The global pharmaceutical company Sanofi is buying Bioverativ Inc., a developer of biologics to treat hemophilia and other rare blood disorders. . . . → Read More: Blood Disorder Drug Maker Acquired in $11.6B Deal One comment - (Comments are closed) Finance biomedical, biotechnology, clinical trials, equity, Europe, genomics, investment, life sciences, merger, pharmaceuticals The biopharmaceutical company Celgene Corp. is acquiring Impact Biomedicines Inc., a developer of drugs to treat a type of blood-related cancer, in a deal valued as much as $7 billion. . . . → Read More: Celgene Acquires Cancer Drug Start-Up in $7B Deal Comments are closed Finance biomedical, biotechnology, cancer, clinical trials, entrepreneurs, equity, licensing, life sciences, merger, pharmaceuticals, university Drug maker Novartis is purchasing a company that develops therapies and diagnostics using radio isotopes for neuroendocrine and other cancers. . . . → Read More: Novartis Acquires Nuclear Meds Developer in $3.9B Deal Comments are closed Finance biomedical, biotechnology, cancer, chemistry, clinical trials, equity, Europe, investment, life sciences, merger, pharmaceuticals, physical sciences, physics Our friends at Statista yesterday published this chart showing Google/Alphabet’s largest acquisitions over the years. . . . → Read More: Infographic – Google’s Largest Acquisitions A company developing personal cancer therapies that genetically engineer a patient’s immune system cells is being acquired in a deal valued at $11.9 billion. . . . → Read More: Engineered T-Cell Company Acquired for $11.9 Billion One comment - (Comments are closed) Finance biomedical, biotechnology, cancer, clinical trials, entrepreneurs, equity, investment, licensing, life sciences, merger, NIH, pharmaceuticals A company providing whole genome analysis is acquiring an enterprise developing open-source computational software for biomedical uses, such as precision medicine. . . . → Read More: Genomics Company Acquires Open-Source Biomedical Platform Comments are closed Finance biomedical, computer science, engineering, entrepreneurs, genomics, life sciences, mathematics, medical device, merger, physical sciences, software, university |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
